121326339	121326339	CD	B-NP	O
|	|	NN	I-NP	O
HNH	HNH	NN	I-NP	O
|	|	NN	I-NP	O
03302120	03302120	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4382029	4382029	CD	B-NP	O
|	|	CC	I-NP	O
10/10/2005	10/10/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
pernicious	pernicious	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/17/2005	10/17/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/10/2005	11/10/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
ANDEBE	ANDEBE	NNP	B-NP	O
,	,	,	O	O
VON	VON	NNP	B-NP	O
EDWARD	EDWARD	NNP	I-NP	O
158-09-22-8	158-09-22-8	CD	I-NP	O
Jomongxandmore	Jomongxandmore	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
4/9/05	4/9/05	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LANDERO	LANDERO	NNP	B-NP	O
,	,	,	O	O
SHON	SHON	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	B-protein
ACID	ACID	NN	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
ALBUTEROL	ALBUTEROL	NN	I-NP	I-protein
INHALER	INHALER	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
QID	QID	NNP	I-NP	I-protein
DULCOLAX	DULCOLAX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
BISACODYL	BISACODYL	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
July	July	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Constipation	Constipation	NNP	I-NP	I-protein
CAPTOPRIL	CAPTOPRIL	NNP	I-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/26/05	10/26/05	CD	B-NP	O
by	by	IN	B-PP	O
UVALLES	UVALLES	NNP	B-NP	O
,	,	,	O	O
VERNON	VERNON	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
82926369	82926369	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CAPTOPRIL	CAPTOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/12/05	1/12/05	CD	B-NP	O
by	by	IN	B-PP	O
DEGROAT	DEGROAT	NNP	B-NP	O
,	,	,	O	O
GROVER	GROVER	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
61086359	61086359	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CAPTOPRIL	CAPTOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/12/05	1/12/05	CD	B-NP	O
by	by	IN	B-PP	O
UMBEL	UMBEL	NNP	B-NP	O
,	,	,	O	O
JEROME	JEROME	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
33222417	33222417	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CAPTOPRIL	CAPTOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
VALIUM	VALIUM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
DIAZEPAM	DIAZEPAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Anxiety	Anxiety	NNP	I-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/12/05	1/12/05	CD	B-NP	O
by	by	IN	B-PP	O
GINGLES	GINGLES	NN	B-NP	O
,	,	,	O	O
LUKE	LUKE	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MINERAL	MINERAL	NNP	B-NP	O
OIL	OIL	NNP	I-NP	O
ENEMA	ENEMA	NNP	I-NP	O
PR	PR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
13204613	13204613	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DOCUSATE	DOCUSATE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
MINERAL	MINERAL	NNP	I-NP	O
OIL	OIL	NNP	I-NP	O
,	,	,	O	O
SYSTEMIC/THERA	SYSTEMIC/THERA	NNP	B-NP	O
USE	USE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LACTULOSE	LACTULOSE	NN	I-NP	O
30	30	CD	I-NP	O
MILLILITERS	MILLILITERS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
July	July	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
MILK	MILK	NNP	I-NP	O
OF	OF	IN	B-PP	O
MAGNESIA	MAGNESIA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MAGNESIUM	MAGNESIUM	NNP	I-NP	O
HYDROXIDE	HYDROXIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MILLILITERS	MILLILITERS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
REGLAN	REGLAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOCLOPRAMIDE	METOCLOPRAMIDE	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NIFEREX-150	NIFEREX-150	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
SIMETHICONE	SIMETHICONE	NNP	I-NP	I-protein
80	80	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	I-protein
SUCRALFATE	SUCRALFATE	NNP	I-NP	I-protein
1	1	CD	I-NP	I-protein
GM	GM	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	B-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
MULTIVI	MULTIVI	NN	I-NP	I-protein
...	...	:	O	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/1/05	10/1/05	CD	B-NP	O
by	by	IN	B-PP	O
GONSKA	GONSKA	NNP	B-NP	O
,	,	,	O	O
BERNARD	BERNARD	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
takes	take	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-DNA
ZOCOR	ZOCOR	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	,	O	I-DNA
40	40	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/1/05	10/1/05	CD	B-NP	O
by	by	IN	B-PP	O
PORTLOCK	PORTLOCK	NN	B-NP	O
,	,	,	O	O
GARRY	GARRY	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MULTIVITAMIN	MULTIVITAMIN	NN	B-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
43263579	43263579	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
takes	take	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
TOPAMAX	TOPAMAX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TOPIRAMATE	TOPIRAMATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
MICONAZOLE	MICONAZOLE	NN	I-NP	O
NITRATE	NITRATE	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
POWDER	POWDER	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
MIRALAX	MIRALAX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
POLYETHYLENE	POLYETHYLENE	NN	I-NP	O
GLYCOL	GLYCOL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
17	17	CD	I-NP	O
GM	GM	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
CALTRATE	CALTRATE	NN	I-NP	O
+	+	SYM	B-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	B-protein
CARB	CARB	NN	I-NP	I-protein
+	+	SYM	B-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	I-NP	O
600MG	600MG	NN	I-NP	O
ELEM	ELEM	NN	I-NP	O
CA	CA	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
MAALOX-TABLETS	MAALOX-TABLETS	NNP	I-NP	O
QUICK	QUICK	NNP	I-NP	O
DISSOLVE/CHEWABLE	DISSOLVE/CHEWABLE	NNP	I-NP	O
1-2	1-2	NN	I-NP	B-protein
TAB	TAB	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q6H	Q6H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Upset	Upset	NNP	I-NP	I-protein
Stomach	Stomach	NNP	I-NP	I-protein
NPH	NPH	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
PORK	PORK	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
50	50	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	I-protein
NPH	NPH	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
PORK	PORK	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
30	30	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	I-protein
REGULAR	REGULAR	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
PORK	PORK	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7	7	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
qbreakfast	qbreakfast	VBD	B-VP	O
REGULAR	REGULAR	NNP	B-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PORK	PORK	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
11	11	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
qlunch	qlunch	NN	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PORK	PORK	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7	7	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
qdinner	qdinner	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
July	July	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/9/05	4/9/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
14516432	14516432	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
TRIMETHOPRIM/SULFAMETHOXAZOLE	TRIMETHOPRIM/SULFAMETHOXAZOLE	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
at	at	IN	B-PP	O
hom	hom	NN	B-NP	O
LINEZOLID	LINEZOLID	NNP	B-NP	O
600	600	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q12H	Q12H	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
to	to	TO	B-VP	O
finish	finish	VB	I-VP	O
11/4/05	11/4/05	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
tyramine-containing	tyramine-containing	JJ	I-NP	O
foods	food	NNS	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
SCH	SCH	NN	B-NP	O
Potassium	Potassium	NN	I-NP	O
Chloride	Chloride	NN	I-NP	O
Policy	Policy	NN	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	JJ	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/9/05	4/9/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CAPTOPRIL	CAPTOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	B-protein
aware	aware	JJ	I-NP	I-protein
VITAMIN	VITAMIN	NN	I-NP	I-protein
B12	B12	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CYANOCOBALAMIN	CYANOCOBALAMIN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
30	30	CD	I-NP	I-protein
MCG	MCG	NN	I-NP	I-protein
IM	IM	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
7	7	CD	I-NP	I-protein
doses	dose	NNS	I-NP	I-protein
VITAMIN	VITAMIN	NN	I-NP	I-protein
B12	B12	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CYANOCOBALAMIN	CYANOCOBALAMIN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
100	100	CD	I-NP	O
MCG	MCG	NN	I-NP	O
IM	IM	NN	I-NP	O
Q4WEEKS	Q4WEEKS	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Edu	Edu	NNP	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
to	to	TO	B-VP	O
arrange	arrange	VB	I-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
PERCOCET	PERCOCET	NN	B-NP	O
,	,	,	O	O
TRIMETHOPRIM/SULFAMETHOXAZOLE	TRIMETHOPRIM/SULFAMETHOXAZOLE	NN	B-NP	O
,	,	,	O	O
INSULINS	INSULINS	NN	B-NP	B-protein
,	,	,	O	O
HUMAN	HUMAN	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
discomfort	discomfort	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
pernicious	pernicious	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
IDDM	IDDM	NNP	I-NP	O
HTN	HTN	NN	I-NP	B-protein
DIABETIC	DIABETIC	NNP	I-NP	I-protein
FOOT	FOOT	NNP	I-NP	I-protein
ABDOMINAL	ABDOMINAL	NNP	I-NP	I-protein
DISTENSION	DISTENSION	NNP	I-NP	I-protein
cad	cad	NN	I-NP	I-protein
pvd	pvd	NN	I-NP	I-protein
S/P	S/P	NN	I-NP	I-protein
ORIF	ORIF	NN	I-NP	I-protein
OF	OF	IN	B-PP	O
ANKLE	ANKLE	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
-RRB-	-RRB-	SYM	O	O
L4/L5	L4/L5	NN	B-NP	O
spondylolisthesis	spondylolisthesis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
spondylolisthesis	spondylolisthesis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
peripheral	peripheral	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
diabetic	diabetic	JJ	I-NP	O
gastroparesis	gastroparesis	NN	I-NP	O
diabetic	diabetic	JJ	I-NP	O
retinopathy	retinopathy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
retinopathy	retinopathy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
carpal	carpal	JJ	I-NP	O
tunnel	tunnel	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
carpal	carpal	JJ	I-NP	O
tunnel	tunnel	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
L	L	NN	I-NP	O
fem-pop	fem-pop	NN	I-NP	O
bypass	bypass	IN	B-PP	O
1997	1997	CD	B-NP	O
s/p	s/p	NN	I-NP	O
skin	skin	NN	I-NP	O
graft	graft	NN	I-NP	O
on	on	IN	B-PP	O
R	R	NN	B-NP	O
heel	heel	NN	I-NP	O
for	for	IN	B-PP	O
ulcers	ulcer	NNS	B-NP	O
1997	1997	CD	B-NP	O
liver	liver	NN	I-NP	O
mass	mass	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
70yo	70yo	CD	B-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
advanced	advance	VBN	B-NP	O
DM	DM	NN	I-NP	O
,	,	,	O	O
MRSA	MRSA	NN	B-NP	B-protein
osteo	osteo	NN	I-NP	I-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
PAD	PAD	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
now	now	RB	B-ADVP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
ab	ab	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
recently	recently	RB	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
NSTEMI	NSTEMI	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
MIBI	MIBI	NN	I-NP	B-protein
with	with	IN	B-PP	O
mod	mod	NN	B-NP	O
LCX	LCX	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
severe	severe	JJ	B-NP	O
HK	HK	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
declined	decline	VBD	B-VP	O
cath	cath	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
currently	currently	RB	B-ADVP	O
being	be	VBG	B-VP	O
tx	tx	NN	B-NP	O
for	for	IN	B-PP	O
osteo	osteo	NN	B-NP	O
with	with	IN	B-PP	O
po	po	NN	B-NP	O
linezolid/levo	linezolid/levo	NN	I-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
3wk	3wk	NN	B-NP	B-protein
course	course	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
declined	decline	VBD	B-VP	O
PICC	PICC	NN	B-NP	O
and	and	CC	O	O
arterial	arterial	JJ	B-NP	B-protein
bipass	bipass	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
in	in	IN	B-PP	O
USOH	USOH	NN	B-NP	O
until	until	IN	B-SBAR	O
24hrs	24hr	NNS	B-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
noted	note	VBD	B-VP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
URI	URI	NN	B-NP	O
sx	sx	NN	I-NP	O
and	and	CC	O	O
fever	fever	NN	B-NP	O
100.2	100.2	CD	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
BRBPR	BRBPR	NN	I-NP	B-protein
,	,	,	O	O
hematuria	hematuria	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
melena	melena	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
:	:	:	O	O
afeb	afeb	NN	B-NP	O
,	,	,	O	O
114/49	114/49	CD	B-NP	O
,	,	,	I-NP	O
90	90	CD	I-NP	O
,	,	,	I-NP	O
90	90	CD	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
2L	2L	NN	I-NP	O
;	;	:	O	O
given	give	VBN	B-NP	O
duoneb	duoneb	NN	I-NP	O
and	and	CC	O	O
lasix	lasix	CD	B-NP	O
40	40	CD	I-NP	O
LABS	LABS	NNP	I-NP	O
:	:	:	O	O
HCT	HCT	NN	B-NP	B-DNA
24	24	CD	I-NP	I-DNA
,	,	,	O	O
Plts	Plt	NNS	B-NP	B-protein
194	194	CD	B-NP	I-protein
,	,	,	O	O
WBC	WBC	NNP	B-NP	B-cell_line
9.1	9.1	CD	I-NP	I-cell_line
,	,	,	O	O
Tn	Tn	NNP	B-NP	B-protein
0.15	0.15	CD	I-NP	I-protein
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
476	476	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
Na	Na	NN	B-NP	B-protein
125	125	CD	I-NP	I-protein
CXR	CXR	NN	I-NP	I-protein
:	:	:	O	O
stable	stable	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
increased	increase	VBN	I-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
but	but	CC	O	O
tech	tech	NN	B-NP	O
poor	poor	JJ	I-NP	O
study	study	NN	I-NP	O
****	****	SYM	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE/PLAN	COURSE/PLAN	NN	I-NP	O
*****	*****	SYM	O	O
70yo	70yo	CD	B-NP	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
new	new	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	B-protein
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV-I	CV-I	NN	I-NP	O
:	:	:	O	O
continue	continue	VB	B-VP	O
ROMI	ROMI	NN	B-NP	B-protein
,	,	,	O	O
positive	positive	JJ	B-NP	B-protein
troponin	troponin	NN	I-NP	I-protein
likely	likely	RB	B-ADJP	O
anemia	anemia	NN	B-NP	O
related	related	JJ	I-NP	O
demand	demand	NN	I-NP	O
;	;	:	O	O
BB	BB	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	O
CV-P	CV-P	NN	I-NP	O
:	:	:	O	O
appears	appear	VBZ	B-VP	O
vol	vol	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
,	,	,	O	O
maybe	maybe	RB	B-ADVP	O
be	be	VB	B-VP	O
2/2	2/2	CD	B-NP	O
to	to	TO	B-VP	O
med/diet	med/diet	VB	I-VP	O
non-compliance	non-compliance	JJ	B-ADJP	O
.	.	.	O	O

Goal	Goal	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
1-2L	1-2L	NN	I-NP	O
/	/	SYM	B-NP	O
d	d	NN	I-NP	O
met	met	NN	I-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
closely	closely	RB	B-ADVP	O
during	during	IN	B-PP	O
transfusions	transfusion	NNS	B-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
8/28	8/28	CD	I-NP	O
showed	show	VBD	B-VP	O
EF	EF	NN	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
RWMA	RWMA	NN	I-NP	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
discharged	discharge	VBD	B-VP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
lasix	lasix	NN	I-NP	O
with	with	IN	B-PP	O
standing	stand	VBG	B-VP	O
potassium	potassium	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
closely	closely	RB	B-ADVP	O
by	by	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV-R	CV-R	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
issues	issue	NNS	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
for	for	IN	B-PP	O
RO	RO	NN	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Heme	Heme	NN	I-NP	O
:	:	:	O	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
2/2	2/2	CD	B-NP	O
to	to	TO	B-PP	O
linezolid	linezolid	JJ	B-NP	O
,	,	,	I-NP	O
other	other	JJ	I-NP	O
possibilities	possibility	NNS	I-NP	O
ACD	ACD	NN	I-NP	O
,	,	,	O	O
CKD	CKD	NN	B-NP	B-protein
,	,	,	O	O
slow	slow	JJ	B-NP	O
GI	GI	NN	I-NP	O
loss	loss	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
guiaic	guiaic	JJ	I-NP	O
neg	neg	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Checking	Check	VBG	B-NP	O
iron	iron	NN	I-NP	O
,	,	,	O	O
retic	retic	JJ	B-NP	O
,	,	,	I-NP	O
smear	smear	NN	I-NP	O
,	,	,	O	O
hemolysis	hemolysis	NN	B-NP	B-protein
labs	lab	NNS	I-NP	I-protein
.	.	.	O	O

Transfuse	Transfuse	NN	B-NP	O
to	to	TO	B-PP	O
goal	goal	NN	B-NP	O
HCT	HCT	NN	I-NP	O
30	30	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
PRBC	PRBC	NN	B-NP	B-protein
on	on	IN	B-PP	O
night	night	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	B-NP	O
then	then	RB	I-NP	O
hct	hct	NN	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
iron	iron	NN	B-NP	O
and	and	CC	I-NP	O
vitamin	vitamin	NN	I-NP	O
B12	B12	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
supplements	supplement	NNS	B-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Renal	Renal	NNP	I-NP	O
:	:	:	O	O
creatinine	creatinine	NN	B-NP	O
at	at	IN	B-PP	O
BL	BL	NNS	B-NP	B-cell_type
at	at	IN	B-PP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
R	R	NN	B-NP	O
calcaneal	calcaneal	JJ	I-NP	O
osteo	osteo	NN	I-NP	O
with	with	IN	B-PP	O
MRSA	MRSA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
bx	bx	NN	I-NP	O
confirmed	confirm	VBD	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
,	,	,	O	O
planned	plan	VBD	B-VP	O
treatment	treatment	NN	B-NP	O
until	until	IN	B-PP	O
8/22	8/22	CD	B-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
last	last	JJ	B-NP	O
discharge	discharge	NN	I-NP	O
summary	summary	NN	I-NP	O
.	.	.	O	O

Change	Change	NN	B-NP	O
to	to	TO	B-VP	O
vanco	vanco	VB	I-VP	O
for	for	IN	B-PP	O
concern	concern	NN	B-NP	O
of	of	IN	B-PP	O
marrow	marrow	NN	B-NP	O
suppresion	suppresion	NN	I-NP	O
of	of	IN	B-PP	O
linezolid	linezolid	NN	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
curbside	curbside	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
linezolid	linezolid	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
treat	treat	NN	B-NP	O
anemia	anemia	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
PRBC	PRBC	NN	I-NP	B-protein
.	.	.	O	O

needs	need	NNS	B-NP	O
6	6	CD	B-NP	O
week	week	NN	I-NP	O
course	course	NN	I-NP	O
from	from	IN	B-PP	O
2/12/05	2/12/05	CD	B-NP	O
.	.	.	O	O

Check	Check	NNP	B-NP	O
BCx	BCx	NNP	I-NP	O
,	,	,	O	O
foot	foot	NN	B-NP	O
films	film	NNS	I-NP	O
show	show	VBP	B-VP	O
no	no	DT	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
,	,	,	O	O
sputum	sputum	NN	B-NP	O
cx	cx	NN	I-NP	O
shows	show	VBZ	B-VP	O
klebsiella	klebsiella	NN	B-NP	O
,	,	,	O	O
likely	likely	RB	B-NP	O
colonizer	colonizer	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
repeatedly	repeatedly	RB	B-NP	O
refused	refuse	VBN	I-NP	O
PICC	PICC	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
believes	believe	VBZ	B-VP	O
abdominal	abdominal	JJ	B-NP	O
discomfort	discomfort	NN	I-NP	O
largely	largely	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
linezolid	linezolid	NN	B-NP	O
.	.	.	O	O

Plastics	Plastic	NNS	B-NP	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
heel	heel	NN	I-NP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
was	be	VBD	B-VP	O
healing	heal	VBG	I-VP	O
nicely	nicely	RB	B-ADVP	O
.	.	.	O	O

To	To	TO	B-VP	O
finish	finish	VB	I-VP	O
up	up	RP	B-PRT	O
6	6	CD	B-NP	O
week	week	NN	I-NP	O
course	course	NN	I-NP	O
from	from	IN	B-PP	O
2/12/05	2/12/05	CD	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
discharged	discharge	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
linezolid	linezolid	NN	B-NP	O
until	until	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
patient	patient	NN	B-NP	O
refused	refuse	VBD	B-VP	O
PICC	PICC	NN	B-NP	O
for	for	IN	B-PP	O
vanco	vanco	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
gastroparesis	gastroparesis	NN	B-NP	O
,	,	,	O	O
giving	give	VBG	B-VP	O
reglan	reglan	NN	B-NP	O
and	and	CC	I-NP	O
sucralfate	sucralfate	NN	I-NP	O
.	.	.	O	O

Aggressive	Aggressive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
finally	finally	RB	B-ADVP	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
miralax	miralax	NN	B-NP	O
and	and	CC	I-NP	O
lactulose	lactulose	NN	I-NP	O
,	,	,	O	O
producing	produce	VBG	B-VP	O
large	large	JJ	B-NP	O
BMs	BM	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
KUB	KUB	NN	I-NP	O
showed	show	VBD	B-VP	O
much	much	JJ	B-NP	O
stool	stool	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	I-NP	O
relief	relief	NN	I-NP	O
of	of	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
distention	distention	NN	I-NP	O
and	and	CC	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulm	Pulm	NNP	I-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
likely	likely	RB	B-ADJP	O
2/2	2/2	CD	B-NP	O
to	to	TO	B-VP	O
pulm	pulm	VB	I-VP	O
edema	edema	NN	B-NP	O
and	and	CC	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
FEN	FEN	NNP	I-NP	O
:	:	:	O	O
hyponatremia	hyponatremia	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
h/o	h/o	NN	B-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
.	.	.	O	O

Free	Free	JJ	B-NP	O
water/fluid	water/fluid	NN	I-NP	O
restrict	restrict	NN	I-NP	O
.	.	.	O	O

Monitor	Monitor	NNP	B-NP	O
.	.	.	O	O

Did	Do	VBD	B-VP	O
not	not	RB	I-VP	O
rise	rise	VB	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
126-7	126-7	CD	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

Unclear	Unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

SIADH	SIADH	NN	B-NP	B-protein
.	.	.	O	O

PCP	PCP	NN	B-NP	O
aware	aware	JJ	I-NP	O
and	and	CC	I-NP	O
informed	inform	VBN	I-NP	O
team	team	NN	I-NP	O
that	that	IN	B-SBAR	O
hyponatremia	hyponatremia	NN	B-NP	O
ongoing	ongoe	VBG	B-VP	O
x	x	NN	B-NP	O
2	2	CD	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Proph	Proph	NNP	I-NP	O
:	:	:	O	O
lovenox	lovenox	NN	B-NP	O
,	,	,	O	O
PPI	PPI	NNP	B-NP	O
FULL	FULL	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
take	take	VB	B-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
may	may	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
more	more	JJR	B-NP	O
medications	medication	NNS	I-NP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
adequate	adequate	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
-LRB-	-LRB-	FW	B-NP	O
e.g.	e.g.	FW	I-NP	O
MOM	MOM	NN	I-NP	O
,	,	,	O	O
miralax	miralax	NN	B-NP	O
,	,	,	O	O
dulcolax	dulcolax	NN	B-NP	O
,	,	,	O	O
lactulose	lactulose	NN	B-NP	O
,	,	,	O	O
colace	colace	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
sharp	sharp	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
please	please	NN	B-NP	O
seek	seek	VBP	B-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
VNA	VNA	NN	B-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
check	check	NN	B-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
give	give	VBP	B-VP	O
vitamin	vitamin	NN	B-NP	O
b12	b12	NN	I-NP	O
IM	IM	NN	I-NP	O
qd	qd	NN	I-NP	O
x	x	SYM	B-VP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
check	check	NN	I-NP	O
potassium	potassium	NN	I-NP	O
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	O
q3d	q3d	NN	I-NP	O
and	and	CC	O	O
send	send	VB	B-VP	O
data	datum	NNS	B-NP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Boak	Boak	NNP	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
ensure	ensure	VB	I-VP	O
patient	patient	NN	B-NP	O
taking	take	VBG	B-VP	O
linezolid	linezolid	NN	B-NP	O
and	and	CC	I-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
as	as	IN	B-PP	O
appropriate	appropriate	JJ	B-ADJP	O
.	.	.	O	O

PLease	PLease	NN	B-NP	B-protein
do	do	VBP	B-VP	O
QD	QD	NN	B-NP	O
dry	dry	JJ	I-NP	O
sterile	sterile	JJ	I-NP	O
dressings	dressing	NNS	I-NP	O
to	to	TO	B-PP	O
lower	low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
AVELES	AVELES	NNP	B-NP	O
,	,	,	O	O
DEE	DEE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TB9	TB9	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/9/05	4/9/05	CD	I-NP	O
@	@	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
11	11	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

